
Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients
Keywords: سرطان ریوی غیر سلول کوچک; AC0010; Avitinib; UPLC-MS/MS; EGFR-TKI; NSCLC; Cerebrospinal fluid;